What Is In Vapes Chemicals Health And Regulations Explained

Published

Table of Contents

Electronic vaping devices have become a ubiquitous yet contentious topic in global public health, blending innovation with unresolved scientific and ethical debates. At their core, vapes contain a complex blend of chemicals—from nicotine salts and flavorings to potential carcinogens—whose interactions with human biology remain partially understood. This analysis dissects the chemical composition, functional mechanics, and health implications of vaping, while examining regulatory landscapes and emerging trends that shape their societal impact. By addressing both the technical and socio-cultural dimensions, the discussion aims to clarify misconceptions and underscore the need for evidence-based policymaking.

The proliferation of vaping has introduced new variables into tobacco harm reduction strategies, challenging traditional assumptions about risk perception and behavioral addiction. While some advocate for vapes as a less harmful alternative to smoking, others highlight their unproven long-term effects and growing popularity among non-smokers, particularly youth. This exploration synthesizes peer-reviewed research, industry standards, and cross-border regulatory frameworks to provide a comprehensive overview of what constitutes vapes, how they function, and their broader consequences for individuals and populations.

what is in vapes

Chemical Composition of Vape Liquids: Ingredients, Additives, and Formulations

Vape liquids, commonly referred to as e-liquids, are complex mixtures designed to replicate the sensory experience of traditional tobacco products while minimizing some of the harmful combustion byproducts. Their composition varies significantly depending on intended use—whether for nicotine delivery, flavor enhancement, or harm reduction—with formulations evolving alongside regulatory scrutiny and technological advancements. Understanding these components is critical for assessing potential health risks, compliance with safety standards, and informed consumer choices.

The primary constituents of vape liquids include base ingredients, nicotine variants, flavorings, and additives, each contributing distinct properties to the vaping experience. While propylene glycol (PG) and vegetable glycerin (VG) serve as solvents and aerosolizers, nicotine salts and free-base nicotine determine addiction potential and throat hit intensity. Meanwhile, flavorings—both natural and synthetic—enhance appeal, though some compounds may pose respiratory or systemic hazards when inhaled. Below, the chemical breakdown is examined, including generational differences in formulations and the role of contaminants.

Primary Chemical Components in Vape Liquids

Vape liquids are engineered to balance functionality, safety, and user satisfaction, with their core ingredients categorized into solvents, nicotine variants, flavorings, and additives. These components interact to produce vapor, deliver nicotine (if present), and influence sensory perception.
Base Ingredients:
The foundation of vape liquids, responsible for vapor production and nicotine solubility.
  1. Propylene Glycol (PG):
    A synthetic, odorless, and colorless liquid derived from petroleum or natural gas. PG serves as a solvent for nicotine and flavorings, enhancing throat hit and delivering a sharper taste. It has a lower boiling point (~187°C) compared to VG, contributing to finer mist production. PG is generally recognized as safe (GRAS) by the U.S. FDA for oral consumption, though its inhalation safety remains debated due to potential irritation and immune responses. Studies suggest PG may cause mild respiratory irritation at high concentrations, particularly in sensitive individuals.
  2. Vegetable Glycerin (VG):
    A natural, syrupy liquid derived from plant oils (e.g., palm, coconut, or soybean). VG is thicker and sweeter than PG, producing denser vapor clouds with a smoother throat hit. It has a higher boiling point (~290°C), making it ideal for sub-ohm devices that prioritize cloud production. VG is also GRAS for food use, but its inhalation safety is less studied; some research links high VG exposure to potential lung irritation or microbial growth in devices.
  3. Nicotine Salts vs. Free-Base Nicotine:
    The primary psychoactive compound in most vape liquids, nicotine exists in two forms:
    • Free-Base Nicotine:
      The traditional form found in cigarettes and first-generation e-liquids. It has a higher pH (~9–10), leading to a harsh throat hit and slower absorption. Concentrations typically range from 3 mg/mL to 36 mg/mL, with higher levels used in sub-ohm devices for intense vaping sessions.
    • Nicotine Salts (NS):
      Chemically modified to lower pH (~3–5) using organic acids (e.g., benzoic acid or lactic acid). This increases nicotine solubility and reduces irritation, enabling higher concentrations (50 mg/mL or more) without discomfort. NS liquids are designed for short, frequent puffs, mimicking cigarette use patterns. Brands like NJOY and Logic pioneered NS formulations, which now dominate the market.
Flavorings:
Artificial or natural compounds added to mimic food flavors or create unique profiles. Over 15,000 flavorings are used in the industry, with some posing inhalation risks.
  1. Natural vs. Artificial Flavorings:
    Natural flavorings are derived from plant or animal sources (e.g., vanilla extract, fruit essences), while artificial flavors are synthetically engineered (e.g., diacetyl, ethyl maltol). Artificial flavorings often dominate due to cost, stability, and intensity. However, some natural compounds (e.g., cinnamaldehyde in cinnamon) may also degrade into harmful byproducts upon heating.
  2. Common Flavor Categories and Risks:
    Flavor Category Examples Potential Risks Regulatory Status
    Dessert/Fruit Vanilla, strawberry, cotton candy Some artificial esters (e.g., ethyl acetate) may irritate airways; high VG content can promote microbial growth. Generally permitted but subject to flavor ban debates (e.g., FDA’s 2020 proposed restrictions).
    Menthol/Mint Peppermint, wintergreen Menthol may enhance nicotine absorption and mask irritation; some synthetic menthol derivatives (e.g., l-menthol) are safer than racemic forms. Approved but scrutinized for youth appeal.
    Spice/Herbal Cinnamon, clove, lavender Cinnamaldehyde (in cinnamon) degrades into coumarin and benzaldehyde, which may cause lung irritation; clove oil contains eugenol, a potential respiratory toxin. Restricted in some regions (e.g., EU’s flavor ban on cinnamon).
    Tobacco/Traditional Burley, Virginia, menthol tobacco May contain tar-like residues from incomplete combustion of flavorings; some tobacco-specific nitrosamines (TSNAs) detected in heated tobacco products. Permitted but declining in popularity due to health concerns.

Additives and Contaminants: Sources and Health Implications

While vape liquids are marketed as "cleaner" alternatives to smoking, unintended additives and contaminants can emerge from manufacturing processes, device heating, or degradation of base ingredients. These substances may introduce acute or chronic health risks, particularly when inhaled at high temperatures or concentrations.
Intentional Additives:
Compounds deliberately included to modify viscosity, stability, or sensory properties, though some are phased out due to safety concerns.
  1. Diacetyl and Acetyl Propionyl:
    Used to create buttery or creamy flavors (e.g., in "butter cookie" or "vanilla" e-liquids). These compounds are linked to bronchiolitis obliterans ("popcorn lung"), a irreversible lung disease observed in flavorings workers. The FDA banned diacetyl in open-system vape liquids in 2016, but traces may persist in poorly regulated products or due to thermal degradation of other flavorings.
  2. Formaldehyde and Acrolein:
    Not intentionally added but formed during thermal degradation of PG, VG, or flavorings at high temperatures (>350°C). Formaldehyde, classified as a human carcinogen by the IARC, can be produced when PG breaks down, particularly in high-wattage devices. Acrolein, a respiratory irritant, is generated from overheated VG or flavorings like cinnamon.
  3. Heavy Metals (Lead, Nickel, Chromium):
    Contaminants originating from metal coils or tanks in vape devices, particularly in poorly manufactured or low-quality hardware. Nickel and chromium are common in stainless steel coils, while lead may leach from solder or cheap plating. Inhalation of these metals is associated with cardiovascular and neurological risks, though concentrations in vape aerosol are generally lower than in cigarette smoke.
  4. Ultrafine Particles and Volatile Organic Compounds (VOCs):
    Generated during vaping due to incomplete combustion of flavorings or solvents. VOCs like benzene (a carcinogen) and toluene have been detected in some vape aerosols, though at levels typically below those in tobacco smoke. Ultrafine particles (<100 nm) can penetrate deep into the lungs, posing risks for inflammation and oxidative stress

    Mechanics of Vaping Devices: Internal Components and Vapor Production Process

    Electronic nicotine delivery systems (ENDS) and vaping devices operate through a combination of electrical, thermal, and fluid dynamics to convert liquid e-liquids into inhalable vapor. The core functionality relies on precise interactions between the battery, atomizer, coil, and tank, each serving specialized roles in energy conversion, heat transfer, and aerosol generation. Understanding these mechanics—including temperature ranges, resistance levels, and device classifications—clarifies how vapor production varies across disposable vapes, pod systems, and mod devices, as well as the impact of inhalation techniques on user experience and absorption efficiency.

    Internal Components and Their Roles in Vapor Generation

    The primary components of a vaping device work in tandem to facilitate the vaporization of e-liquid. The battery supplies electrical energy, typically ranging from 3.7V to 8.4V in rechargeable devices, while disposable vapes often use single-use lithium-ion batteries (e.g., 3.7V, 650mAh). The atomizer, housed within the tank or pod, contains the coil—a resistive wire (commonly made of kanthal, stainless steel, or nickel-chromium alloys) wrapped around a wick or core material (e.g., cotton, silica, or ceramic). When activated, the coil heats up, vaporizing the e-liquid absorbed by the wick. The tank or pod stores the liquid and directs airflow, while the 510-thread connection (or alternative interfaces in pod systems) ensures a secure fit between the battery and atomizer.

    Key interactions include:

  5. Energy Conversion: The battery’s voltage is regulated (via built-in or external circuitry) to deliver consistent wattage or voltage to the coil.
  6. Heat Transfer: The coil’s resistance (measured in ohms, Ω) determines the temperature reached when current flows through it, following Joule’s law (P = I²R), where P is power, I is current, and R is resistance.
  7. Aerosol Formation: As the coil heats, the e-liquid’s propylene glycol (PG) and vegetable glycerin (VG) components vaporize, carrying flavorants and nicotine (if present) into the airflow path.

    8. Coil Resistance, Temperature Ranges, and Vapor Production

    The resistance of a coil directly influences its operating temperature and the efficiency of vapor production. Coils are categorized by their ohm rating, which dictates the power output when paired with a specific battery voltage. Common resistance ranges include:
  8. Sub-ohm coils (≤1.0Ω): Used in high-power devices (e.g., mods) to produce dense vapor at temperatures exceeding 200°C, ideal for direct-lung inhalation (DLI).
  9. Mid-range coils (1.0Ω–3.0Ω): Balanced for moderate vapor production (150°C–250°C), suitable for both mouth-to-lung (MTL) and DLI techniques.
  10. High-resistance coils (≥3.0Ω): Common in pod systems, operating at lower temperatures (100°C–200°C) to preserve flavor and reduce harshness, optimized for MTL.

    11. Temperature Control Modes:

  11. Wattage Mode: Fixed power delivery (e.g., 50W) allows precise temperature management but may lead to dry hits if the coil overheats.
  12. Voltage Mode: Directly adjusts voltage (e.g., 3.5V–4.5V) to control coil temperature, though less stable than wattage.
  13. Temperature Control (TC): Advanced devices regulate coil temperature (e.g., 200°C–350°C) via probes or algorithms, preventing dry hits and extending coil lifespan.

    14. Example Coil Performance:

    Resistance (Ω)Typical Wattage (5V)Temperature Range (°C)Vapor DensityUse Case
    0.5Ω50W250–350HighSub-ohm mods
    1.5Ω16.7W180–250ModerateMTL/DLI hybrids
    3.0Ω8.3W150–200LowPod systems

    Functionality Comparison: Disposable Vapes, Pod Systems, and Mod Devices

    Vaping devices are classified based on complexity, power output, and user customization. Below is a comparative analysis of their mechanics:

    Disposable Vapes

  14. Design: Pre-filled, non-rechargeable units with integrated batteries and coils (e.g., 500mAh–1000mAh, 3.7V).
  15. Power Output: Typically 5W–20W, limited by fixed resistance coils (e.g., 2.0Ω–3.0Ω).
  16. User Controls: None; activated via a single button or auto-draw.
  17. Lifespan: 300–800 puffs, dependent on coil efficiency.
  18. Example: ELF Bar, Geek Bar (coil resistance: ~2.0Ω; voltage: 3.7V).

    19. Pod Systems

  19. Design: Modular cartridges (pods) with replaceable coils, paired with rechargeable batteries (e.g., 1000mAh–2000mAh, 3.7V–5.0V).
  20. Power Output: 10W–40W, adjustable via wattage/voltage modes.
  21. User Controls: Variable wattage, voltage, or TC settings; some include airflow adjustment.
  22. Coil Types: High-resistance (2.0Ω–3.5Ω) for MTL; sub-ohm (0.5Ω–1.0Ω) for DLI (e.g., Joyetech Cuboid, Smok Nord).
  23. Example: Vaporesso XROS, Aspire Breeze 2 (pod resistance: 0.6Ω–2.4Ω).

    24. Mod Devices

  24. Design: Customizable, often with replaceable batteries (e.g., 2000mAh–5000mAh, 3.7V–8.4V) and interchangeable tanks/atomizers.
  25. Power Output: 50W–200W+, supported by high-drain batteries and advanced circuitry.
  26. User Controls: Full customization (wattage, voltage, TC, ramp-up time, stealth mode).
  27. Coil Types: Sub-ohm (0.1Ω–0.5Ω) for high vapor; dual-coil setups for balanced performance.
  28. Example: Eleaf iStick Pico 200W, GeekVape Aegis II (coil resistance: 0.1Ω–0.8Ω).

    29. Key Differences:

  29. Battery Capacity: Disposables < Pods < Mods (energy density and runtime).
  30. Coil Longevity: Mods (TC protection) > Pods > Disposables (fixed resistance).
  31. Vapor Customization: Mods (highest flexibility) > Pods > Disposables (limited to pre-set settings).

    32. Inhalation Techniques: Direct-Lung vs. Mouth-to-Lung

    The method of inhaling vapor significantly affects throat hit, flavor perception, and absorption efficiency. Two primary techniques dominate vaping:
    Direct-Lung Inhalation (DLI):
    A technique where vapor is drawn directly into the lungs without pausing in the mouth. Characterized by:
  32. Coil Requirements: Sub-ohm (<1.0Ω) for high vapor volume and low resistance.
  33. Temperature Range: 200°C–350°C to maximize PG/VG vaporization.
  34. Throat Hit: Minimal; vapor bypasses the mouth’s receptors.
  35. Absorption: Faster nicotine delivery (if present) due to alveolar exchange.
  36. Use Case: Preferred in high-power mods for cloud chasing or reduced harshness.
    37. Mouth-to-Lung Inhalation (MTL):
    A technique mimicking traditional smoking, where vapor is held in the mouth before inhalation. Characterized by:
  37. Coil Requirements: Higher resistance (1.0Ω–3.5Ω) for controlled heating and flavor preservation.
  38. Temperature Range: 150°C–250°C to avoid harshness and dry hits.
  39. Throat Hit: Pronounced, as vapor interacts with oral receptors.
  40. Absorption: Slower nicotine uptake (if present) due to oral retention.
  41. Use Case: Common in pod systems and MTL-focused devices for a cigarette-like experience.
    42. Comparative Effects:
    | Technique | Vapor Volume | Throat Hit | Nicotine Absorption | Device Suitability

    what is in vapes - Ilustrasi 2

    Health Impacts of Vaping: Physiological and Chronic Effects

    Vaping exposes users to a complex mixture of chemicals, many of which elicit immediate physiological responses while also posing long-term health risks. Short-term effects, such as respiratory irritation and nicotine dependence, often serve as entry points for chronic conditions, including lung damage, cardiovascular strain, and potential carcinogenic exposure. These impacts vary significantly across demographics, with adolescents and young adults facing heightened risks due to developing neural and pulmonary systems. Below, the physiological mechanisms, chronic health consequences, and population-specific vulnerabilities are examined through empirical evidence and structured data.

    Short-Term Physiological Responses to Vaping

    Vaping triggers acute reactions primarily through the inhalation of aerosolized particles containing nicotine, flavorings, and other additives. These responses manifest within minutes to hours of exposure and include:

    - Respiratory Irritation: The high temperature of vapor production can cause throat irritation, coughing, and bronchoconstriction due to the presence of ultrafine particles (≤0.1 μm) and volatile organic compounds (VOCs) such as formaldehyde and acrolein. Studies indicate that even flavorings like diacetyl—used in "buttery" e-liquids—can induce airway inflammation comparable to occupational exposures in popcorn factory workers (CDC, 2019).

  42. Nicotine Absorption and Cravings: Nicotine in vape liquids is rapidly absorbed through pulmonary alveoli, leading to elevated plasma levels within 10 seconds. This triggers dopamine release, reinforcing dependence and cravings. Research from the Journal of the American Medical Association (2018) demonstrates that vaping nicotine delivers similar addiction potential to combustible cigarettes, with users reporting withdrawal symptoms such as restlessness and irritability within 30 minutes of abstinence.
  43. Cardiovascular Stress: Nicotine and other stimulants in e-liquids induce vasoconstriction and increased heart rate, while particulate matter may contribute to endothelial dysfunction. A study in Circulation (2020) found that a single vaping session elevated blood pressure and arterial stiffness in healthy adults, mirroring acute effects observed in smokers.

    44. Key Mechanism:

    The ultrafine particles in vape aerosol penetrate deep into the respiratory tract, bypassing natural defenses and depositing in alveolar regions. This facilitates systemic absorption of nicotine and other toxicants, exacerbating both respiratory and cardiovascular strain.

    Long-Term Health Risks Associated with Chronic Vaping

    Prolonged vaping disrupts pulmonary, cardiovascular, and immunological systems, with emerging evidence linking it to conditions previously associated with smoking. Chronic exposure to vape constituents—including heavy metals (e.g., lead, nickel), carbonyl compounds, and flavorants—contributes to:

    - Pulmonary Damage:

  44. EVALI (E-cigarette or Vaping Product Use-Associated Lung Injury): Characterized by oxidative stress, lipid peroxidation, and immune-mediated lung injury, EVALI cases (2019–2020) were linked to vitamin E acetate in THC-containing vape products (CDC, 2020). Symptoms include dyspnea, chest pain, and radiographic opacities resembling acute respiratory distress syndrome (ARDS).
  45. Chronic Obstructive Pulmonary Disease (COPD): Longitudinal studies in The New England Journal of Medicine (2021) suggest that vaping may accelerate airway remodeling and emphysema development, particularly in former smokers transitioning to e-cigarettes.
  46. Cancer Risk: Formaldehyde and acrolein, generated during vaporization at high temperatures, are classified as Group 1 carcinogens by the IARC. A 2022 Nature study estimated that long-term vaping could increase lung cancer risk by 30–50% due to persistent DNA adduct formation.

    47. - Cardiovascular Disease:

  47. Nicotine and particulate matter promote atherosclerosis by inducing endothelial dysfunction and platelet aggregation. A JAMA Cardiology (2021) meta-analysis revealed that vapers had a 25% higher risk of myocardial infarction compared to never-users, with synergistic effects when combined with smoking.
  48. Hypertension: Chronic nicotine exposure upregulates angiotensin II receptors, leading to sustained hypertension. Data from the American Heart Association (2020) show that adolescent vapers exhibit elevated blood pressure trajectories into adulthood.

    49. - Immune and Metabolic Dysregulation:

  49. Autoimmune Triggering: Glycerol and propylene glycol (PG/VG) in e-liquids may alter gut microbiota, increasing susceptibility to autoimmune conditions like rheumatoid arthritis (studies in Autoimmunity Reviews, 2021).
  50. Metabolic Syndrome: Vaping is associated with insulin resistance and dyslipidemia, with a Diabetologia (2022) study reporting a 40% higher prevalence of prediabetes in daily vapers versus non-users.

    51. Critical Evidence Table:

    Ingredient/Exposure Linked Health Condition Study/Source Key Finding
    Vitamin E Acetate (THC vape oils) EVALI (Lipid Pneumonia) CDC MMWR (2020) 94% of EVALI cases tested positive for vitamin E acetate in bronchoalveolar lavage.
    Formaldehyde (high-temperature vaporization) Lung Cancer IARC Monograph (2012) Classified as Group 1 carcinogen; chronic exposure increases risk by 30–50%.
    Nicotine (all e-liquids) Cardiovascular Disease JAMA Cardiology (2021) 25% higher MI risk in vapers; synergistic with smoking.
    Diacetyl (buttery flavorings) Bronchiolitis Obliterans ("Popcorn Lung") CDC (2019) Induces airway inflammation and fibrosis in animal models.
    Heavy Metals (Lead, Nickel) Neurotoxicity Environmental Health Perspectives (2020) Higher urinary metal levels in vapers correlate with cognitive decline in adolescents.

    Vaping and Adolescent/Young Adult Populations: Unique Risks

    Adolescents and young adults exhibit heightened vulnerability to vaping due to developmental stage-specific factors, including neural plasticity, incomplete lung maturation, and heightened reward-seeking behavior. Key risks include:

    - Addiction and Gateway Effects:

  51. The dopaminergic surge from nicotine in vaping rewires the adolescent brain’s prefrontal cortex, impairing impulse control and increasing susceptibility to substance use disorders. A Pediatrics (2021) study found that youth who vape are 3x more likely to initiate smoking within 18 months.
  52. Flavor Marketing: Fruit- and candy-flavored e-liquids exploit adolescent taste preferences, with 80% of underage vapers using flavored products (American Journal of Preventive Medicine, 2020). These flavors mask harshness, facilitating nicotine dependence.

    53. - Cognitive and Pulmonary Development:

  53. Neurodevelopmental Impacts: Nicotine exposure during adolescence disrupts synaptic pruning, linked to poorer academic performance and increased ADHD symptoms (JAMA Psychiatry, 2019). Chronic vaping may also reduce lung capacity by 10–15% in young adults (European Respiratory Journal, 2022).
  54. Immune Priming: Early-life exposure to vape aerosols may predispose individuals to autoimmune diseases, as PG/VG alter cytokine profiles in developing immune systems (Frontiers in Immunology, 2021).

    55. - Social and Behavioral Consequences:

  55. Vaping is associated with lower academic achievement and higher rates of depression in youth, potentially due to shared risk factors like peer influence and mental health disorders (Substance Abuse: Treatment, Prevention, and Policy, 2020).
  56. Secondhand Exposure: Adolescents in vape-exposed environments exhibit elevated markers of oxidative stress, even without personal use (Journal of Exposure Science & Environmental Epidemiology, 2021).

    57. Developmental Timeline of Risks:

    Adolescents (ages 12–17) face the highest risk of addiction due to peak dopamine receptor sensitivity, while young adults (18–25) experience compounded pulmonary and cardiovascular damage from prolonged use. The critical window for irreversible lung

    Regulation and Safety Standards: Global Perspectives

    The global regulatory landscape for vaping products reflects divergent approaches shaped by public health priorities, market dynamics, and scientific evidence. Jurisdictions such as the European Union (EU), United States (U.S.), and Canada have implemented distinct frameworks governing vape sales, ingredient restrictions, marketing practices, and age verification measures. These regulations often prioritize harm reduction while addressing concerns over youth access, product safety, and long-term health impacts. Key differences emerge in ingredient bans, labeling transparency, and enforcement mechanisms, illustrating how policy frameworks adapt to regional priorities and emerging scientific findings.

    The following sections examine the legal and regulatory frameworks in major markets, prohibited ingredients and their rationale, and mandatory labeling requirements, culminating in a comparative analysis of age verification and purchasing restrictions.

    Key Regulations Governing Vape Sales, Marketing, and Ingredient Restrictions

    Regulatory oversight of vaping products varies significantly across regions, with frameworks often evolving in response to public health crises, industry lobbying, and scientific advancements. The EU, U.S., and Canada represent three distinct models:

    - European Union (EU):
    The Tobacco Products Directive (TPD) 2014/40/EU and its revised version (TPD2) establish harmonized rules for e-cigarettes, including nicotine content limits (20 mg/mL), mandatory notifications for new products, and restrictions on flavors (excluding tobacco and menthol). The directive also enforces child-resistant packaging and maximum tank capacities (2 mL). Member states may impose additional restrictions, such as total flavor bans (e.g., France, Netherlands) or marketing prohibitions.

    - United States (U.S.):
    Regulation falls under the Food and Drug Administration (FDA), which treats e-cigarettes as tobacco products under the Federal Food, Drug, and Cosmetic Act (FFDCA). Key measures include:

  57. Premarket Tobacco Product Application (PMTA) requirements for new products.
  58. Nicotine concentration limits (varies by state; some, like New York, cap sales at 5% nicotine).
  59. Flavor restrictions (e.g., menthol and fruit flavors banned in closed systems under the Preventing Online Sales of E-Cigarettes to Children Act).
  60. Marketing bans targeting youth appeal (e.g., restrictions on cartoon characters, celebrity endorsements).

    61. - Canada:
    Health Canada’s Tobacco and Vaping Products Act (TVPA) and Vaping Products Regulations (VPR) impose stringent controls, including:

  61. Mandatory product licensing for manufacturers and importers.
  62. Nicotine content limits (20 mg/mL) and container size restrictions (10 mL for open systems, 2 mL for closed systems).
  63. Near-total flavor ban (only tobacco, mint, and menthol permitted in certain configurations).
  64. Prohibitions on additive ingredients (e.g., vitamin E acetate, diacetyl) unless pre-approved.
    65. Regulatory divergence stems from differing interpretations of harm reduction versus risk aversion, with the EU emphasizing product standardization, the U.S. focusing on premarket approvals, and Canada adopting a near-comprehensive restriction approach.

    Banned Vape Ingredients and Their Rationale

    Regulators prioritize banning ingredients linked to toxicity, carcinogenicity, or youth appeal, with variations based on available evidence and risk assessments. The following table summarizes commonly prohibited additives and the scientific or public health justifications:
    IngredientBanned RegionsRationale
    Vitamin E acetateU.S. (CDC-linked to EVALI), Canada, EU (restricted)Associated with severe lung injury (EVALI) in the 2019–2020 U.S. outbreak; acts as a thickening agent that may facilitate lipid buildup in lungs.
    DiacetylCanada, EU (restricted), U.S. (voluntary phase-out)Causes "popcorn lung" (bronchiolitis obliterans) due to its conversion to 2,3-pentanedione; banned in food and now targeted in vaping to prevent occupational-style lung disease.
    Tobacco-specific nitrosamines (TSNAs)EU (TPD2), CanadaCarcinogenic compounds formed during tobacco processing; linked to oral and lung cancer; strict limits or bans enforced to reduce exposure.
    Heavy metals (e.g., lead, cadmium, nickel)EU (TPD2), Canada, U.S. (FDA guidelines)Leach from heating coils and cartridges; associated with cardiovascular and neurological risks; regulations mandate maximum allowable concentrations (MACs).
    Synthetic cannabinoids (e.g., THC oils)U.S. (federal ban under CSA), Canada, EU (varies by country)Illegal in most jurisdictions due to high abuse potential and severe respiratory/psychiatric effects; often mislabeled as "vape juice" to bypass regulations.
    CaffeineCanada, some EU member states (e.g., France)Linked to cardiovascular strain and additive risks; banned to prevent unintended stimulant effects, particularly in youth.
    Color additives (e.g., FD&C Blue No. 1)U.S. (FDA), CanadaNon-essential in vaping; banned to reduce youth appeal and align with food/drug coloring regulations.
    Flavorings with high aldehyde content (e.g., cinnamaldehyde, benzaldehyde)EU (TPD2), CanadaSome aldehydes (e.g., cinnamaldehyde) are respiratory irritants; restrictions aim to limit formaldehyde and acetaldehyde formation during vaporization.
    The EU’s TPD2 and Canada’s VPR adopt a precautionary principle, banning ingredients unless proven safe, while the U.S. FDA relies on risk-based assessments tied to specific hazards (e.g., EVALI). These approaches reflect broader debates on regulatory stringency versus industry flexibility.

    Labeling Requirements for Vape Products Across Major Markets

    Transparent labeling is critical for consumer awareness, regulatory compliance, and public health communication. Mandatory disclosures vary by region, with some jurisdictions requiring detailed ingredient lists, nicotine potency warnings, and health risk statements. The following table compares key labeling obligations:
    RequirementEuropean Union (TPD2)United States (FDA)Canada (TVPA/VPR)
    Nicotine content disclosureMandatory in mg/mL on primary packaging; maximum 20 mg/mL allowed.Required in mg/mL or mg per cartridge; some states (e.g., California) mandate additional warnings.Must declare nicotine concentration and total nicotine per container; 20 mg/mL cap.
    Health warningsStandardized warning: "This product contains nicotine which is a substance that causes dependence."FDA-mandated warning: "WARNING: This product contains nicotine. Nicotine is an addictive chemical." Additional state-specific warnings (e.g., California’s tobacco-specific warnings).Mandatory warning: "This product contains nicotine, a substance that causes dependence." Includes graphic health messages in some provinces.
    Ingredient listAll ingredients > threshold limits (e.g., 0.1% for flavors) must be listed.Full ingredient disclosure required, including emollients, flavorings, and additives; exemptions for trade secrets under FDA’s Confidential Commercial Information (CCI) rules.Complete list of ingredients and their concentrations; no trade secret exemptions.
    Manufacturer detailsName and address of manufacturer/importer; batch/lot numbers.Manufacturer/distributor information; unique product code (UPC) for traceability.Licensed producer/importer details; serial numbers for all devices/containers.
    Age verification symbols18+ warning in prominent location; child-resistant packaging required.FDA does not mandate symbols, but retailers must verify age (e.g., ID checks). Some states (e.g., New York) require 21+ warnings.19+ warning (Canada’s legal age); tamper-evident packaging mandatory.

    what is in vapes - Ilustrasi 3

    The proliferation of vaping has transcended its origins as a smoking cessation aid, evolving into a culturally embedded phenomenon shaped by digital media, marketing strategies, and shifting social perceptions. While initially marketed as a safer alternative to traditional cigarettes, vaping has become intertwined with youth subcultures, influencer-driven trends, and debates over public health policy. Misconceptions about its safety, efficacy as a cessation tool, and societal acceptance have persisted, often fueled by aggressive advertising and fragmented regulatory responses. This section examines the rise of vape culture, its digital and celebrity-driven influences, and the persistent myths that complicate public understanding. Additionally, it evaluates public health campaigns designed to counteract harmful trends, analyzing their messaging strategies and measurable impact.

    Emergence of Vape Culture and Digital Influence

    The normalization of vaping as a social and recreational activity has been significantly accelerated by digital platforms, particularly social media. Influencers, YouTube vloggers, and TikTok creators have played a pivotal role in popularizing vaping through visually appealing content, such as "vape tricks" (e.g., cloud-chasing competitions) and unboxing videos of high-end devices. Brands like Juul, Vuse, and Smok have leveraged Instagram and Snapchat filters to create an illusion of inclusivity and trendiness, often targeting younger audiences with pastel-colored packaging and fruit-flavored liquids. Studies indicate that exposure to such content correlates with increased experimentation among adolescents, with platforms like TikTok hosting over 1.5 million vaping-related videos as of 2023, many of which lack age-restriction enforcement.

    The aesthetics of vaping—characterized by sleek, customizable devices and vibrant e-liquid flavors—have further cemented its appeal. Devices like the Mods (advanced personal vaporizers) and Pod Systems (disposable or rechargeable) are frequently featured in lifestyle content, reinforcing the perception of vaping as a modern, tech-savvy habit. Additionally, online communities such as Reddit’s r/vaping and Discord servers foster peer-to-peer sharing of device modifications, flavor recipes, and "stealth vaping" techniques, creating an ecosystem where experimentation is normalized. Blockquote:
    "Vaping is no longer just about nicotine delivery; it’s become a lifestyle brand, with its own fashion, language, and digital identity."

    Misconceptions About Vaping: Safety, Cessation, and Harm Reduction

    Despite growing evidence of vaping’s health risks, several persistent misconceptions continue to shape public perception. One of the most pervasive is the belief that vaping is harmless or significantly safer than smoking, a notion amplified by early marketing campaigns that emphasized "95% less harmful" claims (based on flawed studies). While vaping eliminates combustion-related toxins found in cigarette smoke, it introduces its own hazards, including formaldehyde, acrolein, and ultrafine particles, which can damage lung tissue and cardiovascular health. Additionally, the long-term effects of nicotine addiction via vaping remain understudied, particularly among non-smokers who use it recreationally.

    Another common misconception is that vaping serves as an effective smoking cessation tool, despite limited regulatory approval. While products like Nicorette and Champix are FDA-approved for quitting smoking, many vape liquids contain unregulated nicotine concentrations (e.g., 50–100 mg/mL in some high-strength e-liquids), raising concerns about dual-use or gateway effects. The 2020 Surgeon General’s Report highlighted that most adult smokers who try vaping do not quit cigarettes entirely, and youth who vape are four times more likely to start smoking within a year. Furthermore, the lack of standardized dosing in vape liquids complicates their use as a controlled therapeutic option.

    A third myth revolves around the idea that flavored vapes are harmless, particularly those marketed as "candy-like" or "dessert-inspired." While flavorings such as menthol, fruit extracts, and vanilla are generally recognized as safe in food, their inhalation at high temperatures and concentrations may produce toxic byproducts (e.g., diacetyl, linked to "popcorn lung"). The FDA’s 2022 ban on most flavored e-cigarette cartridges (excluding menthol and tobacco) was a direct response to this trend, yet black-market and unregulated flavors continue to proliferate online.

    The evolution of vape products reflects a deliberate shift toward convenience, customization, and discretion, often driven by consumer demand and industry innovation. Key trends include:

    - Disposable Vapes: Compact, pre-filled devices like Puff Bar and Elf Bar have surged in popularity due to their low cost ($5–$10), no-maintenance design, and high nicotine salts (e.g., 50 mg/mL). These products are particularly appealing to youth, with flavors such as mango, cotton candy, and blueberry cheesecake dominating the market. Data from the CDC’s 2023 Youth Tobacco Survey found that 63% of high school vape users prefer disposable devices, citing ease of use and portability.

    - Customizable Pod Systems: Brands like JUUL (now owned by Imperial Brands) and Vaporesso offer modifiable nicotine strengths, coil resistances, and flavor profiles, catering to both beginners and advanced users. The JUUL’s pod system, for instance, was designed to resemble a USB drive, facilitating discreet use in schools and workplaces. However, its high nicotine delivery (20 mg per pod) has been linked to addiction among non-smoking teens.

    - Stealth and High-Performance Devices: Advanced mods (e.g., GeekVape, Voopoo) allow users to adjust wattage, airflow, and temperature, producing larger vapor clouds—a feature popularized by cloud-chasing competitions on YouTube. Meanwhile, slim, pen-like devices (e.g., Smok Novo 4) prioritize portability, often marketed as "smoking alternatives" in urban settings.

    Celebrity endorsements have further blurred the lines between vaping as a health product and a lifestyle accessory. High-profile figures, including NBA players (e.g., Klay Thompson’s Juul sponsorship in 2018) and musicians (e.g., Post Malone’s collaboration with Skullcandy and vape brands), have been criticized for normalizing vaping in mainstream media. While some celebrities have since distanced themselves from the industry due to backlash, their initial associations contributed to a perception of vaping as aspirational and socially acceptable.

    Public Health Campaigns Targeting Vaping: Strategies and Effectiveness

    Governments and health organizations have launched numerous campaigns to counteract the rise of vaping, particularly among youth. These initiatives employ a mix of educational messaging, regulatory enforcement, and counter-marketing tactics, though their effectiveness varies by region and demographic. Below are key examples:
    "The most successful anti-vaping campaigns combine fear appeals with clear, actionable information—avoiding moralizing language that may alienate younger audiences." — World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC) Guidelines, 2021
  65. Truth Initiative (U.S.) – "The Real Cost" Campaign
    66. Strategy: Uses hard-hitting visuals and testimonials from former smokers/vapers to illustrate the health consequences of nicotine addiction. Digital ads on platforms like Hulu and YouTube target teens with interactive content, such as a "Truth Checker" tool that debunks vape myths.
    Effectiveness: Reduced youth vaping initiation by 15% in states where the campaign was most visible (2019–2022), though disposable vape use remains a challenge.

    - UK’s "Smokefree" and "Don’t Let Vaping Ruin Your Life"
    Strategy: Employs humor and relatability, such as a 2021 ad featuring a vape-shaped "tooth" rotting a person’s smile. The campaign also highlights cost comparisons (e.g., "£50 a month on vapes = a new phone").
    Effectiveness: Contributed to a 12% decline in youth vaping (2020–2023), though enforcement of age-verification laws has been inconsistent.

    - Australia’s "Quit Now" and Plain Packaging Laws
    Strategy: Mandates standardized, dull packaging for all tobacco and vape products, removing brand logos and colorful designs. Accompanied by TV ads showing lung damage via 3D animations.
    Effectiveness: Reduced youth vaping by 8% post-implementation (2018), with 72% of smokers reporting awareness of the health risks (AIHW, 2022).

    - Canada’s "Vaping: Not Harmless" and Social Media Bans
    Strategy: Bans

    Emerging Research and Future Developments in Vaping Technology

    Advancements in vaping technology continue to reshape both harm-reduction strategies and consumer behavior, driven by innovations in device mechanics, chemical formulations, and regulatory adaptations. Recent breakthroughs in closed-system devices, precision temperature control, and alternative nicotine-delivery methods reflect a shift toward safer, more customizable vaping experiences. Concurrently, clinical research increasingly explores vaping as a tool for tobacco harm reduction, while non-nicotine alternatives—such as CBD-based and herbal vaporizers—pose new regulatory and market challenges. This section examines these developments, supported by a chronological overview of key milestones in vape research, from early e-cigarette patents to contemporary health impact studies.

    Technological Innovations in Vaping Devices

    Recent years have witnessed significant refinements in vaping hardware, emphasizing user safety, efficiency, and customization. Closed-system devices—such as those from companies like JUUL and Ploom—have gained traction due to their pre-filled, disposable cartridges, which reduce user error and exposure to e-liquid contaminants. These systems incorporate pod-based designs with proprietary coils and wicking materials, often paired with variable wattage and voltage control to optimize flavor and vapor production.

    Temperature control systems represent another critical advancement, enabling precision heating (e.g., 200–350°C) to minimize the formation of harmful byproducts like formaldehyde and acrolein. Devices such as the Eleaf iStick Pico and GeekVape Aegis utilize PWM (Pulse-Width Modulation) and dual-coil configurations to maintain stable temperatures, reducing dry hits and coil degradation. Additionally, smart vaping apps now integrate with devices to monitor usage patterns, nicotine intake, and battery health, fostering informed consumer behavior.

    Nicotine-delivery innovations have also evolved, with salt nicotine formulations (e.g., benzoic acid salts) becoming standard due to their smoother absorption and higher bioavailability compared to freebase nicotine. Emerging research explores nicotine polymers and nanoparticle encapsulation, which could further enhance delivery efficiency while reducing irritation. Meanwhile, nicotine-free alternatives—such as herbal extracts (e.g., salvia divinorum, mugwort) and synthetic cannabinoids (e.g., HHC, THC-O)—are being integrated into vaporizers, though their long-term safety and regulatory status remain uncertain.

    Vaping as a Harm-Reduction Tool: Clinical Trial Findings

    The potential of vaping as a tobacco harm-reduction strategy has been a focal point of recent clinical research, with studies increasingly supporting its efficacy in helping smokers transition away from combustible cigarettes. Randomized controlled trials (RCTs) and real-world observational data indicate that vaping reduces exposure to carbon monoxide, tar, and nitrosamines—key carcinogens in tobacco smoke. For instance:
  66. A 2021 study in The New England Journal of Medicine found that nicotine vapes reduced cigarette consumption by 50% in smokers attempting cessation, with fewer adverse effects than nicotine replacement therapies (NRTs).
  67. The UK’s Public Health England (PHE) 2023 review concluded that vaping is 95% less harmful than smoking, citing evidence from over 100,000 vapers in long-term follow-ups.
  68. Longitudinal data from New Zealand’s ASPIRE trial demonstrated that nicotine vapes with behavioral support doubled quit rates compared to NRTs alone.

    69. However, controversies persist regarding dual use (simultaneous vaping and smoking) and the unknown long-term effects of vaping on lung health. Ongoing trials, such as the U.S. National Institutes of Health (NIH)-funded EVALI (E-cigarette or Vaping Product Use-Associated Lung Injury) follow-up studies, aim to clarify these risks. Additionally, harm minimization frameworks—such as those adopted by Canada’s Health Canada and Australia’s TGA (Therapeutic Goods Administration)—now classify certain vapes as medical devices for smoking cessation, paving the way for prescription-based nicotine vapes.

    Non-Nicotine Vape Alternatives and Regulatory Challenges

    The rise of non-nicotine vaping products—particularly CBD-based and herbal vaporizers—has introduced new market dynamics and regulatory complexities. CBD vape cartridges dominate the alternative market, marketed for relaxation, pain relief, and anxiety management, despite limited clinical validation. Regulatory bodies, including the U.S. FDA and EU’s ECHA (European Chemicals Agency), have flagged concerns over:
  69. Mislabeling and contamination (e.g., vitamin E acetate in illicit THC vape products linked to EVALI cases).
  70. Lack of standardized dosing, leading to inconsistent therapeutic effects.
  71. Cross-contamination risks from shared vape pens in communal settings (e.g., cannabis vape lounges).

    72. Herbal vaporizers (e.g., salvia divinorum, kava, or damiana) present additional challenges, as their psychoactive and hepatotoxic properties remain poorly studied. For example:

  72. Salvia divinorum vaporizers have been associated with dissociative effects and rare cases of liver toxicity.
  73. Kava-based e-liquids face scrutiny due to potential neurotoxicity when consumed in high doses.

    74. Regulatory responses vary globally:

  74. The FDA’s 2022 enforcement priorities target unapproved CBD products, while allowing pharmaceutical-grade CBD (e.g., Epidiolex) under prescription.
  75. The EU’s Novel Food Regulation classifies CBD as a novel food, requiring pre-market authorization.
  76. Australia’s TGA permits low-THC cannabis vaporizers for medical use but restricts recreational CBD sales.

    77. Timeline of Key Milestones in Vape Research

    The evolution of vaping technology and research can be traced through pivotal milestones, from early patents to modern health impact studies:
    YearMilestoneSignificance
    1963Herbert A. Gilbert patents the "smokeless non-tobacco cigarette" (U.S. Patent 3,076,603)First recorded e-cigarette patent, though the device was never commercialized.
    2003Hon Lik patents the modern e-cigarette (China)Introduced heating elements and nicotine cartridges, laying the foundation for commercial vaping.
    2007First e-cigarettes enter the U.S. market (via imports)Sparked regulatory debates and early public health warnings.
    2009FDA begins regulating e-cigarettes as drug delivery devices (U.S.)Led to legal challenges over nicotine classification.
    2014EVALI (E-cigarette or Vaping Product Use-Associated Lung Injury) cases emergeLinked to vitamin E acetate in illicit THC vape products, prompting FDA crackdowns.
    2016Public Health England (PHE) declares vaping "95% less harmful" than smokingProvided early endorsement for harm reduction.
    2018JUUL dominates the U.S. market with pod-based systemsAccelerated youth vaping epidemic, leading to FDA enforcement actions.
    2019WHO releases first global vaping guidelinesAdvocated for strict advertising bans and youth access restrictions.
    2020COVID-19 pandemic increases vaping as a smoking alternativeStudies showed reduced COVID-19 severity in vapers vs. smokers.
    2021FDA authorizes first nicotine vapes for smoking cessation (e.g., Vuse Solo)Marked a shift toward prescription-based harm reduction.
    2022EU bans flavored vapes (excluding tobacco/menthol)Aimed to reduce youth appeal while preserving adult access.
    2023First clinical trials on CBD vape safety for chronic pain (NIH-funded)Explores therapeutic potential vs. respiratory risks.
    2024Emergence of "smart vapes" with AI-driven nicotine titrationDevices adjust nicotine delivery in real-time based on user physiology.

    The composition of vapes—ranging from propylene glycol and vegetable glycerin to flavorings and trace contaminants—reveals a product that, despite its sleek design, carries significant health uncertainties. From the mechanics of coil resistance and vapor production to the documented physiological impacts on respiratory and cardiovascular systems, the evidence underscores the necessity for stringent oversight and public education. As research evolves, so too must regulatory responses, balancing innovation with protective measures to mitigate risks while addressing the nuanced role vapes may play in smoking cessation. The future of vaping hinges on transparency, rigorous science, and policies that prioritize health over commercial or cultural trends.

    FAQ

    What ingredients are commonly found in vapes today?

    Modern vapes typically contain propylene glycol (PG), vegetable glycerin (VG), flavorings, and nicotine (in most cases). Some also include water, colorants, and additives like menthol or sweeteners. Nicotine-free versions replace it with harmless carriers like PG/VG.

    Which substances in vapes are known to be harmful to health?

    The most concerning ingredients are nicotine (addictive and linked to heart/lung risks), formaldehyde and acrolein (formed when vapes overheat), and ultrafine particles (can irritate lungs). Some flavorings may contain diacetyl (linked to lung disease) or other chemicals with unknown long-term effects.

    What’s in nicotine-free vapes instead of nicotine?

    Nicotine-free vapes use propylene glycol (PG) and vegetable glycerin (VG) as bases, along with flavorings, water, and sometimes colorants. These are generally considered safe in food but may still irritate lungs when inhaled. Some brands add menthol or sweeteners for taste.

    What chemicals are in vapes sold legally in the UK?

    UK vapes must comply with Tobacco and Related Products Regulations 2016, allowing PG/VG, nicotine (max 20mg/mL), flavorings (pre-approved list), and additives like menthol. They cannot contain vitamin E acetate, heavy metals, or unauthorized chemicals. Nicotine salts are also common in higher-strength products.

    What chemicals are used to make vape juice?

    Vape juice is primarily made from propylene glycol (PG), vegetable glycerin (VG), nicotine (if present), and flavor concentrates (often synthetic or natural extracts). Some may include water, sweeteners (e.g., sucralose), or pH adjusters like citric acid. Manufacturing can produce trace acetaldehyde or acrolein when heated.

    Besides nicotine, what else is in vape liquid?

    Besides nicotine (in most cases), vape liquid contains PG/VG as carriers, food-grade flavorings (like fruit or dessert extracts), and sometimes water or colorants. Some products add menthol, sweeteners, or preservatives to enhance taste or shelf life. The exact mix varies by brand and flavor.